Live Chat ×
Skip to main content

Invasive Urothelial Carcinoma

Evaluated by: David B. Kaminsky, M.D., FIAC, May 21, 2017
Original release date: November 17, 2017
Access to this course expires on:
May 19, 2020
CME/SAMs 1.5

Faculty: Donna E. Hansel, M.D., Ph.D.

Learning Objectives:
  1. Understand the main subdivision of invasive bladder neoplasia
  2. Identify key urothelial carcinoma variants and understand their clinical significance
  3. Correctly apply immunohistochemistry in the context of invasive urothelial carcinoma
To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here.
blog comments powered by Disqus